Low-dose IL-2 therapy — a complex scenario that remains to be further explored
Crossref DOI link: https://doi.org/10.1038/nrrheum.2017.71
Published Online: 2017-05-11
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Humrich, Jens Y.
Riemekasten, Gabriela
Text and Data Mining valid from 2017-05-11
Article History
First Online: 11 May 2017
Competing interests
: The authors declare no competing financial interests.